Jefferies maintained a Buy rating on Rigel Pharmaceuticals (NASDAQ: RIGL) and raised its price target to $21.00 (from $14.00).

This article: 106 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE